6-Chloro-9-isopropyl-9H-purine

Catalog No.: 
ACVPZC256
CAS No.: 
500539-08-2
Molecular Formula: 
C8H9ClN4
Molecular Weight: 
196.64
6-Chloro-9-isopropyl-9H-purine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$65.00InquiryInquiry
1g95%$131.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-9-isopropyl-9H-purine
IUPAC Name6-chloro-9-isopropyl-9H-purine
MDL No.MFCD07440137
Molecular FormulaC8H9ClN4
Molecular Weight196.64
SMILESCC(C)N1C=NC2=C1N=CN=C2Cl
InChI KeyRZIIMNOJHLWYNA-UHFFFAOYSA-N
Synonym6-chloro-9-isopropyl-9H-purine;9H-Purine, 6-chloro-9-(1-methylethyl)-
CAS No.500539-08-2
PubChem CID414634

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACVPZC256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACAELZ742 route compound structure diagram
    ACAELZ7427403-46-5In Stock
  6. Then
  7. ACVPZC256 route product structure diagram
    ACVPZC256500539-08-2
Inquiry

2. ACVPZC256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACASTC204 route compound structure diagram
    ACASTC20487-42-3In Stock
  4. Then
  5. ACVPZC256 route product structure diagram
    ACVPZC256500539-08-2
Inquiry

3. ACVPZC256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVPZC256 route product structure diagram
    ACVPZC256500539-08-2
Inquiry

Comments (0)